Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration.

Sellers SL, Turner CT, Sathananthan J, Cartlidge TRG, Sin F, Bouchareb R, Mooney J, Nørgaard BL, Bax JJ, Bernatchez PN, Dweck MR, Granville DJ, Newby DE, Lauck S, Webb JG, Payne GW, Pibarot P, Blanke P, Seidman MA, Leipsic JA.

JACC Cardiovasc Imaging. 2019 Jan;12(1):135-145. doi: 10.1016/j.jcmg.2018.06.028. Epub 2018 Nov 15.

PMID:
30448122
2.

Tropoelastin enhances nitric oxide production by endothelial cells.

Hiob MA, Trane AE, Wise SG, Bernatchez PN, Weiss AS.

Nanomedicine (Lond). 2016 Jun;11(12):1591-7. doi: 10.2217/nnm-2016-0052. Epub 2016 May 13.

3.

Deciphering the binding of caveolin-1 to client protein endothelial nitric-oxide synthase (eNOS): scaffolding subdomain identification, interaction modeling, and biological significance.

Trane AE, Pavlov D, Sharma A, Saqib U, Lau K, van Petegem F, Minshall RD, Roman LJ, Bernatchez PN.

J Biol Chem. 2014 May 9;289(19):13273-83. doi: 10.1074/jbc.M113.528695. Epub 2014 Mar 19.

4.

Caveolin as a potential drug target for cardiovascular protection.

Sellers SL, Trane AE, Bernatchez PN.

Front Physiol. 2012 Jul 18;3:280. doi: 10.3389/fphys.2012.00280. eCollection 2012.

5.

Targeting endothelial dysfunction in vascular complications associated with diabetes.

Sharma A, Bernatchez PN, de Haan JB.

Int J Vasc Med. 2012;2012:750126. doi: 10.1155/2012/750126. Epub 2011 Oct 13.

6.

β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions.

Sharma V, Sharma A, Saran V, Bernatchez PN, Allard MF, McNeill JH.

Eur J Pharmacol. 2011 Apr 25;657(1-3):117-25. doi: 10.1016/j.ejphar.2011.01.044. Epub 2011 Feb 4.

PMID:
21296063
7.

New insights into caveolae, caveolins and endothelial function.

Sharma A, Yu C, Bernatchez PN.

Can J Cardiol. 2010 Mar;26 Suppl A:5A-8A. Review.

PMID:
20386752
8.

Myoferlin is critical for endocytosis in endothelial cells.

Bernatchez PN, Sharma A, Kodaman P, Sessa WC.

Am J Physiol Cell Physiol. 2009 Sep;297(3):C484-92. doi: 10.1152/ajpcell.00498.2008. Epub 2009 Jun 3.

9.

Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo.

Tourkina E, Richard M, Gööz P, Bonner M, Pannu J, Harley R, Bernatchez PN, Sessa WC, Silver RM, Hoffman S.

Am J Physiol Lung Cell Mol Physiol. 2008 May;294(5):L843-61. doi: 10.1152/ajplung.00295.2007. Epub 2008 Jan 18.

10.

Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function.

Bernatchez PN, Acevedo L, Fernandez-Hernando C, Murata T, Chalouni C, Kim J, Erdjument-Bromage H, Shah V, Gratton JP, McNally EM, Tempst P, Sessa WC.

J Biol Chem. 2007 Oct 19;282(42):30745-53. Epub 2007 Aug 16.

11.

Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase.

Fernández-Hernando C, Fukata M, Bernatchez PN, Fukata Y, Lin MI, Bredt DS, Sessa WC.

J Cell Biol. 2006 Jul 31;174(3):369-77. Epub 2006 Jul 24.

12.

Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides.

Bernatchez PN, Bauer PM, Yu J, Prendergast JS, He P, Sessa WC.

Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):761-6. Epub 2005 Jan 6.

13.

Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis.

Bauer PM, Yu J, Chen Y, Hickey R, Bernatchez PN, Looft-Wilson R, Huang Y, Giordano F, Stan RV, Sessa WC.

Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):204-9. Epub 2004 Dec 22.

14.

Sphingosine 1-phosphate effect on endothelial cell PAF synthesis: role in cellular migration.

Bernatchez PN, Tremblay F, Rollin S, Neagoe PE, Sirois MG.

J Cell Biochem. 2003 Nov 1;90(4):719-31.

PMID:
14587028
15.

Antisense inhibition of Flk-1 by oligonucleotides composed of 2'-deoxy-2'-fluoro-beta-D-arabino- and 2'-deoxy-nucleosides.

Lacombe J, Viazovkina E, Bernatchez PN, Galarneau A, Damha MJ, Sirois MG.

Can J Physiol Pharmacol. 2002 Oct;80(10):951-61.

PMID:
12450061
16.

Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.

Gélinas DS, Bernatchez PN, Rollin S, Bazan NG, Sirois MG.

Br J Pharmacol. 2002 Dec;137(7):1021-30.

17.

Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase.

Geraldes P, Sirois MG, Bernatchez PN, Tanguay JF.

Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1585-90.

PMID:
12377734
18.

Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.

Bernatchez PN, Rollin S, Soker S, Sirois MG.

J Cell Biochem. 2002;85(3):629-39.

PMID:
11968003
19.

Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways.

Bernatchez PN, Allen BG, Gélinas DS, Guillemette G, Sirois MG.

Br J Pharmacol. 2001 Nov;134(6):1253-62.

20.

Vascular endothelial growth factor production by isolated rat hepatocytes after cold ischemia-warm reoxygenation.

Archambault AJ, Sirois MG, Bernatchez PN, Fiset C, Haddad PS.

Liver Transpl. 2001 Nov;7(11):988-97.

21.

VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2.

Bernatchez PN, Winstead MV, Dennis EA, Sirois MG.

Br J Pharmacol. 2001 Sep;134(1):197-205.

Supplemental Content

Loading ...
Support Center